XML 33 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net income attributable to common stockholders $ 13,751 $ 13,059
Adjustments to reconcile net income to net cash provided by operating activities:    
Net accretion on debt securities (78) (64)
Depreciation expense 2,174 2,371
Negative provision for credit losses (3,175) (475)
Net loss (gain) on equity securities 856 (447)
Net realized gain on sale of debt securities 0 (12)
Deferred tax asset valuation allowance 0 1,792
Increase in mortgage servicing rights resulting from transfers of financial assets (332) (218)
Mortgage servicing rights amortization and impairment, net 534 615
Amortization of intangible assets 715 755
Amortization of restricted stock 631 722
Loss on closure of branch facilities 0 380
Decrease in deferred income taxes 380 202
Increase in cash surrender value of life insurance (954) (693)
Net (gain) loss from disposals of foreclosed and repossessed assets (19) 62
Provision for valuation allowance on foreclosed properties 313 0
Gain on sale of loans held for sale, net (2,216) (1,692)
Proceeds from sale of loans held for sale 60,347 46,907
Originations of loans held for sale (53,687) (50,988)
Net change in:    
Accrued interest receivable and other assets (1,775) 54
Other liabilities 2,711 794
Total adjustments 6,425 65
Net cash from operating activities 20,176 13,124
Cash flows from investing activities:    
Proceeds from Bank Owned Life Insurance (“BOLI”) death benefit 499 0
Net decrease in other interest bearing deposits 0 249
Purchase of available-for-sale securities 0 (11,007)
Proceeds from principal payments of available-for-sale securities 14,842 16,594
Proceeds from sales of available-for-sale securities 0 5,105
Proceeds from principal payments and maturities of held-to-maturity securities 5,707 5,134
Equity investment capital distribution 276 132
Purchase of equity investments (450) (1,350)
Net sales of other investments 520 284
Proceeds from sales of foreclosed and repossessed assets 877 307
Proceeds from insurance claim on foreclosed and repossessed assets 27 0
Net decrease (increase) in loans 92,317 (48,298)
Net capital expenditures (889) (1,367)
Proceeds from disposal of office properties and equipment 13 12
Net cash from investing activities 113,739 (34,205)
Cash flows from financing activities:    
Change in short term in Federal Home Loan Bank advances, net (44,000) (68,000)
Federal Home Loan Bank advance call payments (10,000) (15,000)
Federal Home Loan Bank advances 0 25,000
Federal Home Loan Bank maturities (20,530) (5,000)
Amortization of debt issuance costs 224 223
Other borrowings principal reductions (6,083) (5,167)
Net (decrease) increase in deposits (30,952) 94,361
Restricted common stock awarded under the equity incentive plan 0 1
Repurchase shares of common stock (6,097) (421)
Surrender of restricted shares of common stock (119) (129)
Common stock options exercised 22 28
Cash dividends paid (3,346) (3,040)
Net cash from financing activities (120,881) 22,856
Net decrease in cash and cash equivalents 13,034 1,775
Cash and cash equivalents at beginning of period 37,138 35,363
Cash and cash equivalents at end of period 50,172 37,138
Cash paid during the period for:    
Interest on deposits 34,446 23,353
Interest on borrowings 5,116 10,180
Income taxes 2,318 3,977
Supplemental noncash disclosure:    
Transfers from loans receivable to foreclosed and repossessed assets 274 158
Transfers from office properties and equipment to foreclosed and repossessed assets $ 0 $ 724